3 Best Performing ASX shares in week 3, 17 January 2022

Marc Kennis Marc Kennis, January 24, 2022

3 Best performing ASX shares: American Rare Earths (ASX:ARR) almost doubled last week. It was up 94.9%, while Morella Corporation (ASX:1MC) was up 89.5%. Lastly, Genetic Technologies (ASX:GTG) was up a very solid 50% last week and wraps up the top 3 best performing ASX shares.

 

1. American Rare Earths (ASX:ARR)

Industry: Basic Materials

American Rare Earths Limited (ARR, formerly Broken Hill Prospecting) is an Australian exploration company focussed on the discovery and development of strategic mineral resources across two primary geographical areas; the Murray Basin Region (Heavy Mineral Sands) and the Broken Hill Region (industrial, base and precious metals, including the Thackaringa Cobalt and base/precious metal project).

Market Cap: $148M

12 month high / low: $0.545 – $0.066

 

American Rare Earths

 

 

2. Morella Corporation (ASX:1MC)

Industry: Chemicals

Morella Corporation Limited (1MC, formerly Altura Mining Limited) is an exploration and mineral resource development company, focused on lithium and battery minerals. Morella is currently engaged in exploration activities on two project opportunities, strategically located in Tier 1 mining jurisdictions in both Australia and the United States.

Market Cap: $185M

12 month high / low: $0.045 – $0.01

 

Morella Corporation

 

 

3. Genetic Technologies (ASX:GTG)

Industry: Technology

Genetic Technologies Limited (ASX:GTG) is a diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women’s health. The company’s lead products are GeneType for Breast Cancer for non-hereditary breast cancer and GeneType for Colorectal Cancer are clinically validated risk assessment tests and are first in class. 

Market Cap: $55m

12 month high / low: $0.004 – $0.014

 

genetic techologies

 

 

Learn more about ASX-listed stocks with
Stocks Down Under!

 

Subscribe to Stocks Down Under today!

 

GET A 30-DAY FREE TRIAL

 

No credit card needed and the trial expires automatically.

 

 

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

Nuix

Nuix (ASX:NXL) has quadrupled in 12 months! But is more growth to come?

Nuix (ASX:NXL) has been one of the most controversial companies on the ASX since it listed, but has it turned…

ASX Biotechs

Here are 3 ASX biotechs with major milestones coming right up!

Investing in ASX biotechs is a risky business, even more than most other companies on the market. Unless you own…

buy the dip

When do you know it’s time to ‘buy the dip’? You could be catching a falling knife

‘Buy the dip’ – have you ever heard that term? It implies that when a company’s share price ‘dips’ or decreases,…